These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4910188)

  • 21. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipramine pamoate in hospitalized depressives: a double-blind comparison with placebo.
    Karkalas Y; Lal H
    Psychosomatics; 1970; 11(2):107-11. PubMed ID: 4919175
    [No Abstract]   [Full Text] [Related]  

  • 23. [A double-blind comparison between mianserin and imipramine (author's transl)].
    Pull CB; Pichot P; Dreyfus JF
    Acta Psychiatr Belg; 1978; 78(5):827-32. PubMed ID: 375686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A placebo-controlled double-blind study of imipramine and trazodone in geriatric depression.
    Gerner R; Estabrook W; Steuer J; Waltuch L; Kakkar P; Jarvik L
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():167-82. PubMed ID: 7413649
    [No Abstract]   [Full Text] [Related]  

  • 25. A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illnesses.
    Rogers SC; Clay PM
    Br J Psychiatry; 1975 Dec; 127():599-603. PubMed ID: 1104034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J; Schless AP
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression associated with alcohol withdrawal. Imipramine therapy compared with placebo.
    Butterworth AT
    Q J Stud Alcohol; 1971 Jun; 32(2):343-8. PubMed ID: 4932253
    [No Abstract]   [Full Text] [Related]  

  • 29. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.
    Rabkin JG; Rabkin R; Harrison W; Wagner G
    Am J Psychiatry; 1994 Apr; 151(4):516-23. PubMed ID: 7908501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative trial of imipramine and phenobarbital in depressed patients seen in general practice.
    Wheatley D
    J Nerv Ment Dis; 1969 May; 148(5):542-9. PubMed ID: 4889754
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.
    Raskin A; Schulterbrandt JG; Reatig N; McKeon JJ
    Arch Gen Psychiatry; 1970 Aug; 23(2):164-73. PubMed ID: 4913665
    [No Abstract]   [Full Text] [Related]  

  • 34. DL-phenylalanine versus imipramine: a double-blind controlled study.
    Beckmann H; Athen D; Olteanu M; Zimmer R
    Arch Psychiatr Nervenkr (1970); 1979 Jul; 227(1):49-58. PubMed ID: 387000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
    McGrath PJ; Stewart JW; Nunes EV; Ocepek-Welikson K; Rabkin JG; Quitkin FM; Klein DF
    Am J Psychiatry; 1993 Jan; 150(1):118-23. PubMed ID: 8417553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double blind clinical study comparing doxepin and imipramine in depression.
    Hasan KZ; Akhtar MI
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):327-36. PubMed ID: 4996218
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study.
    Angst J; Woggon B; Schoepf J
    Arch Psychiatr Nervenkr (1970); 1977 Oct; 224(2):175-86. PubMed ID: 336002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressants in black and white inpatients. Differential response to a controlled trial of chlorpromazine and imipramine.
    Raskin A; Crook TH
    Arch Gen Psychiatry; 1975 May; 32(5):643-9. PubMed ID: 1092283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative trial of imipramine N-oxide and imipramine in the treatment of out-patients with depressive syndromes.
    Rapp W; Norén MB; Pedersen F
    Acta Psychiatr Scand; 1973; 49(1):77-90. PubMed ID: 4572170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.